Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2016 2
2017 1
2018 4
2019 6
2020 7
2021 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Potential biomarkers of kaposiform lymphangiomatosis.
Ozeki M, Nozawa A, Kawamoto N, Fujino A, Hirakawa S, Fukao T. Ozeki M, et al. Among authors: nozawa a. Pediatr Blood Cancer. 2019 Sep;66(9):e27878. doi: 10.1002/pbc.27878. Epub 2019 Jun 17. Pediatr Blood Cancer. 2019. PMID: 31207041 Clinical Trial.
Everolimus for Treatment of Pseudomyogenic Hemangioendothelioma.
Ozeki M, Nozawa A, Kanda K, Hori T, Nagano A, Shimada A, Miyazaki T, Fukao T. Ozeki M, et al. Among authors: nozawa a. J Pediatr Hematol Oncol. 2017 Aug;39(6):e328-e331. doi: 10.1097/MPH.0000000000000778. J Pediatr Hematol Oncol. 2017. PMID: 28121744
Immunologic Effects of Sirolimus in Patients With Vascular Anomalies.
Nozawa A, Ozeki M, Yasue S, Endo S, Kawamoto N, Ohnishi H, Fumino S, Furukawa T, Tajiri T, Maekawa T, Fujino A, Souzaki R, Fukao T. Nozawa A, et al. J Pediatr Hematol Oncol. 2020 Jul;42(5):e355-e360. doi: 10.1097/MPH.0000000000001650. J Pediatr Hematol Oncol. 2020. PMID: 31743321
25 results